---
figid: PMC5819363__nihms919488f1
figlink: /pmc/articles/PMC5819363/figure/F1/
number: Figure 1
caption: 'A) Mutations in PHEO/PGL susceptibility genes belonging to the pseudohypoxic
  signaling cluster result in direct or indirect activation of the hypoxia signaling
  (HIF) pathway even in the presence of sufficient amount of oxygen (pseudohypoxia).
  Inactivating mutations in SDHx, SDHAF2, FH, or MDH2 lead to accumulation of Krebs
  cycle metabolites, such as succinate, fumarate, pyruvate, or glutamine, which is
  followed by activation of pseudohypoxic signaling and transcription of HIF target
  genes. VHL, EGLN1/2, and HIF2A genes are directly involved in hypoxic signaling.
  Mutations in these genes are associated with activation of the HIF signaling pathway.
  Pseudohypoxic signaling drives cell proliferation, deregulation of cellular energy
  and metabolism, angiogenesis, invasion and metastasis. B) Kinase signaling cluster
  includes mutations in genes involved in abnormal activation of kinase signaling,
  particularly PI3K/AKT, mTOR, and RAS/MAPK pathways. Activation of these pathways
  is associated with cell proliferation and survival, evasion from apoptosis, and
  chromatin remodeling. Kinase signaling pathways in PHEO and PGL can be disrupted
  by mutations in NF1, KIF1B, MAX, RET, TMEM127, H-RAS, and ATRX genes. Rarely, mutations
  in K-RAS, FGFR genes and fusion genes involving NGFR, BRAF, or NF1 can be found
  in PHEOs/PGLs. C) Recently, the Wnt signaling pathway has been implied to play role
  in PHEO/PGL pathogenesis based on the identification of CSDE1 mutations and MAML3
  fusion genes []. D) Mutations in SDHx and FH genes result in an accumulation of
  succinate and fumarate and mutated IDH1 activity that results in conversion of α-ketoglutarate
  to the oncometabolite D2HG. Succinate, fumarate, D2HG, and L2HG function as competitive
  inhibitors of α-ketoglutarate–dependent dioxygenases. Inhibition of reactions mediated
  by α-ketoglutarate-dependent dioxygenases leads to DNA and histone hypermethylation,
  activation of hypoxic responses, and inhibition of collagen maturation and folding.Abbreviations:
  4EBP1, eukaryotic translation initiation factor 4E binding protein 1; α-KGDH, alpha-ketoglutarate
  dehydrogenase; Acetyl-CoA, acetyl-coenzyme A; ACO, aconitase; AKT, AKT serine/threonine
  kinase; ATRX, ATRX, chromatin remodeler; BRAF, B-Raf proto-oncogene; CS, citrate
  synthase; CSDE1, cold shock domain containing E1; D2HG, D-2-hydroxyglutarate; Dvl,
  Dishevelled segment polarity protein; EGLN1/2/3, egl-9 prolyl hydroxylase 1, 2,
  3; ERK, mitogen-activated protein kinase 1; FGFR, fibrablast growth factor receptor;
  FH, fumarate hydratase; Gli1/2, GLI family zinc finger 1, 2; GLUT, glucose transporter;
  GSK3, glycogen synthase kinase 3; HIF, hypoxia-inducible factor; HIF2A, hypoxia-inducible
  factor 2 alpha; H-RAS, HRas proto-oncogene, GTPase; IDH1/2, isocitrate dehydrogenase
  1, 2; JMJD, Jumoni C domain-containing histone lysine demethylases; KIF1B, kinesin
  family member 1B; K-RAS, KRAS proto-oncogene, GTPase; L2HG, L-2-hydroxyglutarate;
  MAPK, mitogen activated kinase; MAML3, mastermind like transcriptional coactivator
  3; MAX, MYC associated factor X; MDH2, malate dehydrogenase 2; MDM2, MDM2 proto-oncogene;
  mTOR, mechanistic target of rapamycin; MYC, MYC proto-oncogene; NF1, neurofibromin
  1; NGFR, nerve growth factor receptor; PDH, pyruvate dehydrogenase; PHD1/2, egl-9
  family hypoxia inducible factor 2, 1; PHEO/PGL, pheochromocytoma/paraganglioma;
  PI3K, phosphatidylinositol-3-kinase; RAC, Rho guanine nucleotide exchange factors;
  RAS, RAS type GTPase family; RET, RET proto-oncogene; Rheb, Ras homolog enriched
  in brain; ROS, reactive oxygen species; SDHx, succinate dehydrogenase subunits A,
  B, C, D, SDHAF2, succinate dehydrogenase complex assembly factor 2; SMO, Smoothened,
  frizzled class receptor; SUCLG, succinyl-coenzyme A ligase; TETs, tet methylcytosine
  dioxygenases; TMEM127, transmembrane protein 127; TP53, tumor protein 53; TSC1/2,
  TSC complex subunit 1, 2; VHL, von Hippel-Lindau tumor suppressor,'
pmcid: PMC5819363
papertitle: Genomic Landscape of Pheochromocytoma and Paraganglioma.
reftext: Ivana Jochmanova, et al. Trends Cancer. ;4(1):6-9.
pmc_ranked_result_index: '199146'
pathway_score: 0.7972174
filename: nihms919488f1.jpg
figtitle: Genomic Landscape of Pheochromocytoma and Paraganglioma
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5819363__nihms919488f1.html
  '@type': Dataset
  description: 'A) Mutations in PHEO/PGL susceptibility genes belonging to the pseudohypoxic
    signaling cluster result in direct or indirect activation of the hypoxia signaling
    (HIF) pathway even in the presence of sufficient amount of oxygen (pseudohypoxia).
    Inactivating mutations in SDHx, SDHAF2, FH, or MDH2 lead to accumulation of Krebs
    cycle metabolites, such as succinate, fumarate, pyruvate, or glutamine, which
    is followed by activation of pseudohypoxic signaling and transcription of HIF
    target genes. VHL, EGLN1/2, and HIF2A genes are directly involved in hypoxic signaling.
    Mutations in these genes are associated with activation of the HIF signaling pathway.
    Pseudohypoxic signaling drives cell proliferation, deregulation of cellular energy
    and metabolism, angiogenesis, invasion and metastasis. B) Kinase signaling cluster
    includes mutations in genes involved in abnormal activation of kinase signaling,
    particularly PI3K/AKT, mTOR, and RAS/MAPK pathways. Activation of these pathways
    is associated with cell proliferation and survival, evasion from apoptosis, and
    chromatin remodeling. Kinase signaling pathways in PHEO and PGL can be disrupted
    by mutations in NF1, KIF1B, MAX, RET, TMEM127, H-RAS, and ATRX genes. Rarely,
    mutations in K-RAS, FGFR genes and fusion genes involving NGFR, BRAF, or NF1 can
    be found in PHEOs/PGLs. C) Recently, the Wnt signaling pathway has been implied
    to play role in PHEO/PGL pathogenesis based on the identification of CSDE1 mutations
    and MAML3 fusion genes []. D) Mutations in SDHx and FH genes result in an accumulation
    of succinate and fumarate and mutated IDH1 activity that results in conversion
    of α-ketoglutarate to the oncometabolite D2HG. Succinate, fumarate, D2HG, and
    L2HG function as competitive inhibitors of α-ketoglutarate–dependent dioxygenases.
    Inhibition of reactions mediated by α-ketoglutarate-dependent dioxygenases leads
    to DNA and histone hypermethylation, activation of hypoxic responses, and inhibition
    of collagen maturation and folding.Abbreviations: 4EBP1, eukaryotic translation
    initiation factor 4E binding protein 1; α-KGDH, alpha-ketoglutarate dehydrogenase;
    Acetyl-CoA, acetyl-coenzyme A; ACO, aconitase; AKT, AKT serine/threonine kinase;
    ATRX, ATRX, chromatin remodeler; BRAF, B-Raf proto-oncogene; CS, citrate synthase;
    CSDE1, cold shock domain containing E1; D2HG, D-2-hydroxyglutarate; Dvl, Dishevelled
    segment polarity protein; EGLN1/2/3, egl-9 prolyl hydroxylase 1, 2, 3; ERK, mitogen-activated
    protein kinase 1; FGFR, fibrablast growth factor receptor; FH, fumarate hydratase;
    Gli1/2, GLI family zinc finger 1, 2; GLUT, glucose transporter; GSK3, glycogen
    synthase kinase 3; HIF, hypoxia-inducible factor; HIF2A, hypoxia-inducible factor
    2 alpha; H-RAS, HRas proto-oncogene, GTPase; IDH1/2, isocitrate dehydrogenase
    1, 2; JMJD, Jumoni C domain-containing histone lysine demethylases; KIF1B, kinesin
    family member 1B; K-RAS, KRAS proto-oncogene, GTPase; L2HG, L-2-hydroxyglutarate;
    MAPK, mitogen activated kinase; MAML3, mastermind like transcriptional coactivator
    3; MAX, MYC associated factor X; MDH2, malate dehydrogenase 2; MDM2, MDM2 proto-oncogene;
    mTOR, mechanistic target of rapamycin; MYC, MYC proto-oncogene; NF1, neurofibromin
    1; NGFR, nerve growth factor receptor; PDH, pyruvate dehydrogenase; PHD1/2, egl-9
    family hypoxia inducible factor 2, 1; PHEO/PGL, pheochromocytoma/paraganglioma;
    PI3K, phosphatidylinositol-3-kinase; RAC, Rho guanine nucleotide exchange factors;
    RAS, RAS type GTPase family; RET, RET proto-oncogene; Rheb, Ras homolog enriched
    in brain; ROS, reactive oxygen species; SDHx, succinate dehydrogenase subunits
    A, B, C, D, SDHAF2, succinate dehydrogenase complex assembly factor 2; SMO, Smoothened,
    frizzled class receptor; SUCLG, succinyl-coenzyme A ligase; TETs, tet methylcytosine
    dioxygenases; TMEM127, transmembrane protein 127; TP53, tumor protein 53; TSC1/2,
    TSC complex subunit 1, 2; VHL, von Hippel-Lindau tumor suppressor,'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - MYC
  - KRAS
  - WNT1
  - RET
  - MDH2
  - SDHB
  - WNT2
  - NF1
  - WNT4
  - ARNTL
  - SMO
  - ARNT2
  - RHEB
  - HIF1A
  - HIF3A
  - WNT3A
  - EPAS1
  - NGFR
  - VHL
  - CCND1
  - WNT16
  - RAC3
  - HRAS
  - AKT2
  - ATRX
  - CTNNB1
  - CISH
  - CSDE1
  - WNT6
  - TMEM127
  - TSC1
  - RHOG
  - WNT9A
  - MAPK3
  - FGFR1
  - FGFR3
  - FGFR2
  - FGFR4
  - FGFRL1
  - WNT3
  - WNT5A
  - SLC2A1
  - GSK3A
  - CCND2
  - TSC2
  - MAPK1
  - ARNT
  - WNT10B
  - WNT11
  - WNT2B
  - WNT9B
  - WNT10A
  - WNT5B
  - DVL1
  - RAC1
  - GSK3B
  - CCND3
  - AKT3
  - AKT1
  - RAC2
  - KLK15
  - FH
  - DHH
  - DVL2
  - DVL3
  - IHH
  - WNT8A
  - SHH
  - WNT8B
  - WNT7B
  - WNT7A
  - Glucose
  - Lactate
  - Pyruvate
  - Acetyl-CoA
  - Fumarate
  - Oxaloacetate
  - Succinate
  - Citrate
  - Succinyl-CoA
  - KGOH
  - Aconitate
  - Isocitrate
  - Glutamine
  - Fatty acid
  - fatty acid
  - VHL
  - Hypoxia
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: K-RAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: RET
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: MDH2
  symbol: MDH2
  source: hgnc_symbol
  hgnc_symbol: MDH2
  entrez: '4191'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: NGFR
  symbol: NGFR
  source: hgnc_symbol
  hgnc_symbol: NGFR
  entrez: '4804'
- word: HIF-a
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ATRX
  symbol: ATRX
  source: hgnc_symbol
  hgnc_symbol: ATRX
  entrez: '546'
- word: Bcatenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: cis
  symbol: CIS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: CSDE1
  symbol: CSDE1
  source: hgnc_symbol
  hgnc_symbol: CSDE1
  entrez: '7812'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: TMEM127
  symbol: TMEM127
  source: hgnc_symbol
  hgnc_symbol: TMEM127
  entrez: '55654'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: ACO
  symbol: ACO
  source: hgnc_alias_symbol
  hgnc_symbol: KLK15
  entrez: '55554'
- word: FH
  symbol: FH
  source: hgnc_symbol
  hgnc_symbol: FH
  entrez: '2271'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: DHH
  entrez: '50846'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: IHH
  entrez: '3549'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Lactate
  source: MESH
  identifier: D019344
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Fumarate
  source: MESH
  identifier: D005650
- word: Oxaloacetate
  source: MESH
  identifier: D010071
- word: Succinate
  source: MESH
  identifier: D013386
- word: Citrate
  source: MESH
  identifier: C102006
- word: Succinyl-CoA
  source: MESH
  identifier: C012046
- word: KGOH
  source: ''
  identifier: ''
- word: Aconitate
  source: MESH
  identifier: D000156
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Glutamine
  source: MESH
  identifier: C578860
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: fatty acid
  source: MESH
  identifier: D005227
diseases:
- word: VHL
  source: MESH
  identifier: D006623
- word: Hypoxia
  source: MESH
  identifier: D000860
---
